"Markov Chains" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stochastic process such that the conditional probability distribution for a state at any future instant, given the present state, is unaffected by any additional knowledge of the past history of the system.
| Descriptor ID |
D008390
|
| MeSH Number(s) |
E05.318.740.600.500 E05.318.740.996.500 G17.830.500 N05.715.360.750.625.500 N05.715.360.750.770.500 N06.850.520.830.600.500 N06.850.520.830.996.500
|
| Concept/Terms |
Markov Chains- Markov Chains
- Chains, Markov
- Markov Process
- Markov Processes
- Process, Markov
- Processes, Markov
- Markov Chain
- Chain, Markov
|
Below are MeSH descriptors whose meaning is more general than "Markov Chains".
Below are MeSH descriptors whose meaning is more specific than "Markov Chains".
This graph shows the total number of publications written about "Markov Chains" by people in this website by year, and whether "Markov Chains" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 4 | 4 |
| 2004 | 1 | 3 | 4 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 5 | 5 |
| 2008 | 1 | 6 | 7 |
| 2009 | 0 | 6 | 6 |
| 2010 | 0 | 6 | 6 |
| 2011 | 1 | 4 | 5 |
| 2012 | 1 | 5 | 6 |
| 2013 | 0 | 3 | 3 |
| 2014 | 0 | 7 | 7 |
| 2015 | 0 | 5 | 5 |
| 2016 | 0 | 5 | 5 |
| 2017 | 0 | 5 | 5 |
| 2018 | 0 | 7 | 7 |
| 2019 | 0 | 4 | 4 |
| 2020 | 0 | 5 | 5 |
| 2021 | 0 | 3 | 3 |
| 2024 | 0 | 3 | 3 |
| 2025 | 1 | 3 | 4 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Markov Chains" by people in Profiles.
-
Fast Estimation and Valid Statistical Inference for Mixed-Effect Location-Scale Models Using Variational Inference. Stat Med. 2026 Jun; 45(13-14):e70640.
-
Cost Effectiveness of Endovascular Thrombectomy for Large Ischemic Strokes: A US Healthcare Payer Markov Model Informed by Randomized Trials. Appl Health Econ Health Policy. 2026 07; 24(4):777-789.
-
Curcumin-QingDai Combination for Active Ulcerative Colitis: A Cost-Effectiveness Analysis. Value Health. 2026 Jul; 29(7):1162-1170.
-
Clinically Interpretable Survival Risk Stratification in Head and Neck Cancer Using Bayesian Networks and Markov Blankets. Int J Radiat Oncol Biol Phys. 2026 03 01; 124(3):856-867.
-
Limits on the computational expressivity of non-equilibrium biophysical processes. Nat Commun. 2025 Aug 05; 16(1):7184.
-
Predictors of Bi-directional Transitions From Mild Cognitive Impairment in a Diverse Cohort. J Gerontol A Biol Sci Med Sci. 2025 06 10; 80(7).
-
Bayesian Calibration of Stochastic Agent Based Model via Random Forest. Stat Med. 2025 Mar 15; 44(6):e70029.
-
Genicular Artery Embolization, Radiofrequency Ablation, and Corticosteroid Therapy for Knee Osteoarthritis: A Cost-Effectiveness Analysis Using Randomized Clinical Trial Data. AJR Am J Roentgenol. 2024 12; 223(6):e2431710.
-
Impact of next-generation sequencing vs polymerase chain reaction testing on payer costs and clinical outcomes throughout the treatment journeys of patients with metastatic non-small cell lung cancer. J Manag Care Spec Pharm. 2024 Dec; 30(12):1467-1478.
-
Randomized Controlled Trial Based US Commercial Payor Cost-Effectiveness Analysis of Endoscopic Sleeve Gastroplasty Versus Lifestyle Modification Alone for Adults With Class I/II Obesity. Obes Surg. 2024 09; 34(9):3275-3284.